| Oct 31 |
Moderna (MRNA) Stock Moves -0.66%: What You Should Know
|
| Oct 31 |
These 10 Stocks Were S&P 500's Top Performers In Biden's First Year: Could Trend Continue If Harris Wins 2024 Election?
|
| Oct 31 |
Moderna (MRNA): Expanding Horizons in Gene Editing and mRNA Vaccines
|
| Oct 31 |
Is Moderna (NASDAQ:MRNA) Stock a Buy at Current Levels?
|
| Oct 31 |
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
|
| Oct 31 |
Moderna to Present at Upcoming Conferences in November 2024
|
| Oct 30 |
Is Moderna, Inc. (MRNA) The Worst Performing S&P 500 Stock In 2024?
|
| Oct 29 |
Moderna (MRNA) Exceeds Market Returns: Some Facts to Consider
|
| Oct 29 |
Moderna price target lowered to $60 from $105 at Evercore ISI
|
| Oct 29 |
Moderna and MSD begin trial of mRNA-4157 and Keytruda combination for lung cancer
|
